Common factors among Alzheimer's disease, Parkinson's disease, and epilepsy: Possible role of the noradrenergic nervous system

被引:61
|
作者
Szot, Patricia [1 ,2 ]
机构
[1] Vet Adm Puget Sound Hlth Care Syst, NW Network Mental Illness Res Educ & Clin Ctr, Seattle, WA USA
[2] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA
关键词
Alzheimer's disease; Parkinson's disease; Temporal lobe epilepsy; Locus coeruleus; Noradrenergic; Hippocampus; LOCUS-COERULEUS NEURONS; SUBSTANTIA-NIGRA; EFFERENT PROJECTIONS; DEPRESSION; DEMENTIA; CERULEUS; NOREPINEPHRINE; PATHOPHYSIOLOGY; SUBPOPULATIONS; SUSCEPTIBILITY;
D O I
10.1111/j.1528-1167.2012.03476.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The neurodegenerative disorders Alzheimers disease (AD) and Parkinsons disease (PD) share in common the neuropathologic loss of locus coeruleus (LC) noradrenergic neurons. In addition, these two neurodegenerative disorders share two symptoms that define these disorders: cognitive impairment and depression. The hippocampus is a region that is known to play a role in cognition and depression, and the hippocampus receives sole noradrenergic innervation from LC neurons. However, it is unclear how the loss of LC noradrenergic neurons contributes to these common symptoms in these two disorders. Epilepsy is not considered a neurodegenerative disorder, but the hippocampus is severely affected in temporal lobe epilepsy. Of interest, cognitive impairment and depression are also common comorbid disorders in temporal lobe epilepsy. This article describes common symptoms among these three neurologic disorders and a possible role of the noradrenergic nervous system.
引用
收藏
页码:61 / 66
页数:6
相关论文
共 50 条
  • [1] Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease
    McMillan, Pamela J.
    White, Sylvia S.
    Franklin, Allyn
    Greenup, J. Lynne
    Leverenz, James B.
    Raskind, Murray A.
    Szot, Patricia
    BRAIN RESEARCH, 2011, 1373 : 240 - 252
  • [2] The Noradrenergic System in Parkinson's Disease
    Paredes-Rodriguez, Elena
    Vegas-Suarez, Sergio
    Morera-Herreras, Teresa
    De Deurwaerdere, Philippe
    Miguelez, Cristina
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [3] Microstructural integrity of the locus coeruleus and its tracts reflect noradrenergic degeneration in Alzheimer's disease and Parkinson's disease
    Lin, Chen-Pei
    Frigerio, Irene
    Bol, John G. J. M.
    Bouwman, Maud M. A.
    Wesseling, Alex J.
    Dahl, Martin J.
    Rozemuller, Annemieke J. M.
    van der Werf, Ysbrand D.
    Pouwels, Petra J. W.
    van de Berg, Wilma D. J.
    Jonkman, Laura E.
    TRANSLATIONAL NEURODEGENERATION, 2024, 13 (01)
  • [4] The Role of Glymphatic System in Alzheimer's and Parkinson's Disease Pathogenesis
    Buccellato, Francesca R.
    D'Anca, Marianna
    Serpente, Maria
    Arighi, Andrea
    Galimberti, Daniela
    BIOMEDICINES, 2022, 10 (09)
  • [5] The Metabolic Basis for Nervous System Dysfunction in Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease
    Maiese, Kenneth
    CURRENT NEUROVASCULAR RESEARCH, 2023, 20 (03) : 314 - 333
  • [6] Noradrenergic System in Down Syndrome and Alzheimer's Disease A Target for Therapy
    Phillips, Cristy
    Fahimi, Atoossa
    Das, Devsmita
    Mojabi, Fatemeh S.
    Ponnusamy, Ravikumar
    Salehi, Ahmad
    CURRENT ALZHEIMER RESEARCH, 2016, 13 (01) : 68 - 83
  • [7] Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer's disease
    Adori, Csaba
    Glueck, Laura
    Barde, Swapnali
    Yoshitake, Takashi
    Kovacs, Gabor G.
    Mulder, Jan
    Magloczky, Zsofia
    Havas, Laszlo
    Boelcskei, Kata
    Mitsios, Nicholas
    Uhlen, Mathias
    Szolcsanyi, Janos
    Kehr, Jan
    Ronnback, Annica
    Schwartz, Thue
    Rehfeld, Jens F.
    Harkany, Tibor
    Palkovits, Miklos
    Schulz, Stefan
    Hokfelt, Tomas
    ACTA NEUROPATHOLOGICA, 2015, 129 (04) : 541 - 563
  • [8] The Emerging Role of Circular RNAs in Alzheimer's Disease and Parkinson's Disease
    Zhang, Meng
    Bian, Zhigang
    FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
  • [9] An evidence base for noradrenergic deficits in Parkinson's disease
    Halliday, Glenda
    MOVEMENT DISORDERS, 2012, 27 (13) : 1589 - 1591
  • [10] Is it possible to differentiate Alzheimer's disease from Parkinson's disease dementia by praxis tests?
    Sanli, Zeynep Selcan
    Evlice, Ahmet
    Binokay, Hulya
    DUSUNEN ADAM-JOURNAL OF PSYCHIATRY AND NEUROLOGICAL SCIENCES, 2023, 36 (04) : 222 - 229